Sprucegrove Investment Management LTD Merck & Co., Inc. Transaction History

Sprucegrove Investment Management LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$50.83 - $59.72 $2.6 Million - $3.06 Million	-51,200 Closed	0 $0
Q1 2018 May 11, 2018	SELL	$50.96 - $59.23 $2.7 Million - $3.14 Million	-53,000 Reduced 50.86%	51,200 $2.79 Million
Q4 2017 Feb 09, 2018	SELL	$51.62 - $61.64 $712,356 - $850,632	-13,800 Reduced 11.69%	104,200 $5.86 Million
Q3 2017 Nov 08, 2017	BUY	$58.67 - $63.13 $6.92 Million - $7.45 Million	118,000	118,000 $7.56 Million

3,769

1.87B

17.3M

14.8M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $320B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Sprucegrove Investment Management LTD, based on Form 13F filings with the SEC.

Stay updated on Sprucegrove Investment Management LTD with notifications on news.